Introduction
============

Diabetic retinopathy (DR) is a serious microvascular complication of diabetes mellitus and a major cause of decreased vision in working-aged adults.[@b1-opth-8-1331] The risk of a severe decrease in vision can be reduced by effective control of serum glucose and by regular ophthalmic examinations for early detection and appropriate treatment, such as laser photocoagulation.[@b2-opth-8-1331]--[@b6-opth-8-1331] Guidelines for frequency of ophthalmic examinations for early detection and timely treatment have been published.[@b7-opth-8-1331] However, several studies have reported that more than one third of diabetic patients did not follow the guidelines,[@b8-opth-8-1331] and low compliance with ophthalmic examinations was the cause of decreased vision even if vitreous surgery had been performed.[@b9-opth-8-1331] Therefore, better communication with general physicians is necessary to encourage better compliance with regular ophthalmic follow-up examinations. This has been shown to be true in many patients who have less regular ophthalmic examinations even when they have regular general examinations for diabetes.[@b10-opth-8-1331]

Several large cohort studies have reported three major risk factors for DR, ie, duration of diabetes,[@b11-opth-8-1331]--[@b13-opth-8-1331] circulating glycosylated hemoglobin (HbA~1c~) levels,[@b11-opth-8-1331]--[@b15-opth-8-1331] and blood pressure.[@b16-opth-8-1331]--[@b20-opth-8-1331] However, to the best of our knowledge, little has been reported on the clinical features of diabetic patients referred from general physicians due to less ophthalmic examinations. Thus, the purpose of this study was to determine the features of diabetic patients referred from general physicians to the Kansai Medical University Takii Hospital for evaluation of the eyes.

Patients and methods
====================

Patients
--------

The procedures used in this study conformed to the tenets of the Declaration of Helsinki. A total of 327 consecutive patients with type 2 diabetes referred from general physicians to the Department of Ophthalmology, Kansai Medical University Takii Hospital (Osaka, Japan) between April 2009 and March 2012 were studied. Patients who were referred from ophthalmologists or continued to have regular ophthalmic examinations at least once a year were excluded.

At the initial examination, all patients were interviewed regarding their medical history, including any ocular diseases. All underwent a standard ophthalmic examination, including best-corrected visual acuity (BCVA), refraction, slit-lamp examination, and fundus examination with dilated pupils. BCVA was determined as the decimal visual acuity and then converted to logMAR (logarithm of the minimum angle of resolution) units for statistical analysis. In cases where the eyes had different BCVA values, the eye with the lower BCVA was used.

The patients were divided into two groups,[@b9-opth-8-1331] ie, those with a history of missing ophthalmic examinations at our hospital or other ophthalmic clinics for more than a year (noncompliant group) and those without any previous ophthalmic examination since the onset of diabetes mellitus (never-examined group).

Classification of DR and diabetic status
----------------------------------------

The stage of DR was determined by ophthalmoscopy and fluorescein angiography. The patients were classified according to severity of DR, ie, no apparent DR, mild to moderate nonproliferative DR, severe nonproliferative DR, and proliferative DR.[@b21-opth-8-1331] In cases where both eyes had different stages of DR, the eye with the more severe stage was selected for statistical analysis.

Serum HbA~1c~ levels (defined by the Japan Diabetes Society: JDS), serum creatinine, estimated glomerular filtration rate (eGFR), urinary levels of creatinine (uCre) and albumin (uAlb), and urine albumin/creatinine ratio (uACR) were obtained from the medical records and taken on the day closest to the first visit to our clinic.

Statistical analysis
--------------------

The results are expressed as the mean ± standard deviation. Mann--Whitney *U*-tests were used to determine whether differences in the different sets of values were significant. A comparison of the incidence of DR between the non-compliant group and never-examined group was made by computing odds ratios and 95% confidence intervals (CIs). Multiple linear regression analysis was used to analyze the association between severity of DR and clinical parameters. Differences were considered to be statistically significant when the *P*-value was \<0.05. Statistical analysis of the data was performed using IBM^®^ SPSS^®^ Statistics for Windows version 22 (IBM Corporation, Armonk, NY, USA).

Results
=======

Patient characteristics
-----------------------

Of the 327 patients, 124 (38%) belonged to the noncompliant group and 203 (62%) to the never-examined group ([Table 1](#t1-opth-8-1331){ref-type="table"}). The mean overall patient age was 60.0±14.0 years, that of the noncompliant group was 63.0±14.0 years, and that of the never-examined group was 58.1±13.8 years. The noncompliant group was significantly older than the never-examined group (*P*=0.001).

The mean BCVA for all patients was 0.037±0.36 logMAR units, that of the noncompliant group was 0.15±0.53 logMAR units, and that of the never-examined group was −0.03±0.18 logMAR units. The BCVA in the never-examined group was significantly better than that in the noncompliant group (*P*=0.004).

Incidence of DR
---------------

Of the 327 patients, 102 were diagnosed with DR (31.2%, 95% CI 0.26--0.36; [Table 2](#t2-opth-8-1331){ref-type="table"}), 81 with mild to moderate nonproliferative DR (24.8%, 95% CI 0.20--0.30), eleven with severe nonproliferative DR (3.4%, 95% CI 0.02--0.06), and ten with proliferative DR (3.1%, 95% CI 0.01--0.06). The incidences of DR, mild to moderate nonproliferative DR, and proliferative DR in the noncompliant group were significantly higher than the corresponding values in the never-examined group (odds ratios 3.4, 3.3, and 15.8, respectively; *P*\<0.001, *P*\<0.001, and *P*\<0.002; [Table 2](#t2-opth-8-1331){ref-type="table"}). However, the incidence of severe nonproliferative DR was not significantly different between the groups.

Blood chemistry
---------------

HbA~1c~ levels and eGFR in the noncompliant group were significantly lower than the corresponding values in the never-examined group (HbA~1c~ 8.1%±2.0% versus 9.1%±2.4%, *P*\<0.001; eGFR 72.3±25.1 mL/min versus 84.2±29.6 mL/min, *P*=0.003; [Table 3](#t3-opth-8-1331){ref-type="table"}). In contrast, levels of serum creatinine, uAlb, and uACR in the noncompliant group were significantly higher (serum creatinine 1.0±0.8 mg/dL versus 0.9±1.2 mg/dL, *P*=0.020; uAlb 365±1,140 mg/L versus 188±989 mg/L, *P*=0.002; and uACR, 428±1,291 mg/g·Cre versus 176±638 mg/g·Cre, *P*=0.001). The level of uCre was not significantly different between the two groups.

Multiple regression analysis
----------------------------

Multiple regression analysis showed that the severity of DR was significantly correlated with compliance with ophthalmic examination and uACR (adjusted *R*^2^=0.11; *P*=0.047 and *P*\<0.001, respectively; [Table 4](#t4-opth-8-1331){ref-type="table"}), but not with age, BCVA, HbA~1c~, or eGFR.

Discussion
==========

Our results show that diabetic patients referred by general practitioners due to less ophthalmic examinations had four major characteristics. First, the patients had reasonably good visual acuity ([Table 1](#t1-opth-8-1331){ref-type="table"}). Patients generally visited an ophthalmologist without being referred by their general physician if they had some degree of eye symptoms, such as loss of visual acuity or floaters.

Second, the incidence of DR was 31.2% in our study ([Table 2](#t2-opth-8-1331){ref-type="table"}), which is higher than in large two population-based studies in Japan (the Hisayama and Funagata studies), that reported incidences of 16.9%, and 23.0%, respectively, in diabetic patients.[@b12-opth-8-1331],[@b22-opth-8-1331] In the USA, the National Health and Nutrition Examination Survey between 2005 and 2008 found that 28.5% of adults with diabetes had DR.[@b23-opth-8-1331] A recent meta-analysis showed the global prevalence of DR to be 35% in diabetic individuals.[@b24-opth-8-1331] The incidence of DR in our study is similar to the global average, but higher than those in the large studies in Japan and the USA. The reason for this may be that the patients attending our hospital have more severe diabetes than those seen at local clinics.

Third, a habit of missing ophthalmic examinations was a risk factor for DR. The incidence of DR in the noncompliant group was higher than that in the never-examined group ([Table 2](#t2-opth-8-1331){ref-type="table"}), and the severity of DR was significantly correlated with noncompliance ([Table 4](#t4-opth-8-1331){ref-type="table"}). A number of studies have already reported that missing ophthalmic examinations leads to progression of DR and low vision.[@b8-opth-8-1331]--[@b10-opth-8-1331] The reason for this may be that noncompliant patients have had diabetes for longer than patients without previous ophthalmic examinations. However, it is generally difficult to determine the exact duration of type 2 diabetes in patients with the disease. This is also a reason for the poorer values for indices of renal function (eGFR, uAlb, and uACR) in the noncompliant group than in the never-examined group ([Table 3](#t3-opth-8-1331){ref-type="table"}).

Fourth, we found that albuminuria was also a risk factor for DR in our patients. The severity of DR was significantly correlated with uACR, but not with eGFR or HbA~1c~ ([Table 4](#t4-opth-8-1331){ref-type="table"}). uACR is commonly used as an index of albuminuria.[@b25-opth-8-1331] Chen et al and Moriya et al reported that microalbuminuria was a more useful biomarker than moderately decreased eGFR in predicting the severity of DR in patients with type 2 diabetes.[@b26-opth-8-1331],[@b27-opth-8-1331] We found that HbA~1c~ in the never-examined group was higher than that in the noncompliant group ([Table 3](#t3-opth-8-1331){ref-type="table"}), although severity of DR was not correlated with HbA~1c~ ([Table 4](#t4-opth-8-1331){ref-type="table"}). The reason for this may be that the patients in the never-examined group had not had a general examination.

This study has some limitations. First, we did not examine blood pressure, which is a major risk factor for DR. However, blood pressure may not be an appropriate parameter for assessment of DR, because it can be easily altered by hypotensive drugs. Second, this was a retrospective study at a university hospital, so further studies are needed with larger and more diverse samples.

In summary, our results show that diabetic patients referred from general physicians due to less ophthalmic examinations have good visual acuity but one third have DR. In addition, a history of missing ophthalmic examinations and albuminuria are risk factors for DR in these patients. Our results suggest that ophthalmologists need to inform not only their diabetic patients but also general physicians about the need for regular follow-up ophthalmic examinations.

**Disclosure**

The authors report no conflicts of interest in this work.

###### 

Clinical characteristics

  Category            Total        Noncompliant   Never-examined   *P*-value[\*](#tfn2-opth-8-1331){ref-type="table-fn"}
  ------------------- ------------ -------------- ---------------- -------------------------------------------------------
  Patients (n)        327          124            203              N/A
  Age (years)         60.0±14.0    63.0±14.0      58.1±13.8        0.001
  Sex (male/female)   229/98       86/38          143/60           N/A
  BCVA (logMAR)       0.037±0.36   0.15±0.53      −0.03±0.18       0.004

**Notes:** Values are shown as the mean ± standard deviation.

*P*-value between noncompliant group and never-examined group (Mann--Whitney *U*-test).

**Abbreviations:** BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; N/A, not applicable.

###### 

Prevalence of diabetic retinopathy

  Category    Total (%)    Noncompliant (%)   Never-examined (%)   *P*-value[\*](#tfn4-opth-8-1331){ref-type="table-fn"} (OR)
  ----------- ------------ ------------------ -------------------- ------------------------------------------------------------
  Total (n)   327          124                203                  N/A
  DR (n)      102 (31.2)   59 (47.6)          43 (21.2)            \<0.001 (3.4)
   M-NPDR     81 (24.8)    48 (38.7)          33 (16.3)            \<0.001 (3.3)
   S-NPDR     11 (3.4)     2 (1.6)            9 (4.4)              0.29 (0.4)
   PDR        10 (3.1)     9 (13.8)           1 (0.6)              0.002 (15.8)

**Note:**

*P*-value from the comparison of prevalence of DR between never-examined group and noncompliant group.

**Abbreviations:** DR, diabetic retinopathy; M-NPDR, mild to moderate nonproliferative diabetic retinopathy; OR, odds ratio; S-NPDR, severe nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; N/A, not applicable.

###### 

Biochemistry results

  Category          Total       Noncompliant   Never-examined   *P*-value[\*](#tfn7-opth-8-1331){ref-type="table-fn"}
  ----------------- ----------- -------------- ---------------- -------------------------------------------------------
  HbA~1c~ (%)       8.8±2.3     8.1±2.0        9.1±2.4          \<0.001
  sCre (mg/dL)      0.9±1.1     1.0±0.8        0.9±1.2          0.020
  eGFR (mL/min)     79.8±28.6   72.3±25.1      84.2±29.6        0.003
  uCre (mg/dL)      106±78.5    99.8±71.2      110±82.3         0.428
  uAlb (mg/L)       251±1,046   365±1,140      188±989          0.002
  uACR (mg/g·Cre)   266±931     428±1,291      176±638          0.001

**Notes:** Mean ± standard deviation.

*P*-value between noncompliant group and never-examined group (Mann--Whitney *U*-test).

**Abbreviations:** HbA~1c~, glycosylated hemoglobin; sCre, serum creatinine; eGFR, estimated glomerular filtration rate; uCre, urinary creatinine; uAlb, urinary albumin; uACR, urine albumin/creatinine ratio.

###### 

Multiple regression analysis of severity of diabetic retinopathy

  Independent variable                                 β[\*](#tfn10-opth-8-1331){ref-type="table-fn"}   *P*-value
  ---------------------------------------------------- ------------------------------------------------ -----------
  Group[\#](#tfn11-opth-8-1331){ref-type="table-fn"}   −0.14                                            0.047
  Age                                                  0.03                                             0.683
  BCVA                                                 0.05                                             0.466
  HbA~1c~                                              0.13                                             0.053
  eGFR                                                 −0.01                                            0.954
  uACR                                                 0.25                                             \<0.001

**Notes:** Adjusted *R*^2^=0.11 for final BCVA in multiple regression (*P*\<0.001);

standard partial regression coefficient;

noncompliant group or never-examined group.

**Abbreviations:** BCVA, best-corrected visual acuity; HbA~1c~, glycosylated hemoglobin; eGFR, estimated glomerular filtration rate; uACR, urine albumin/creatinine ratio.
